Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F23%3A10458193" target="_blank" >RIV/00669806:_____/23:10458193 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00216208:11140/23:10458193

  • Výsledek na webu

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ku9HjuMvjG" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ku9HjuMvjG</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3390/cancers15030991" target="_blank" >10.3390/cancers15030991</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century

  • Popis výsledku v původním jazyce

    Simple Summary Survival in colon and rectal cancers has internationally developed well, although reliable data span essentially only two decades. For small intestinal cancer, fewer data are available but survival appears to be improving. Overall, the exact causes of survival improvements are not known. During the 50-year period, 5-year survival in colon and rectal cancers improved linearly in Norway, while in Finland and Sweden the rate of improvement decreased with time, which is the opposite to Denmark where the rate increased. In small intestinal cancers, the rate of improvement was linear or increasing. The remarkable Danish achievement of improving relative survival rates more than the other counties coincided with cancer policy planning and instigating economically backed organizational and infrastructural improvements. The slowing survival rates in the other countries call for optimization of the available resources and a search for novel approaches. Background: Survival studies in intestinal cancers have generally shown favorable development, but few studies have been able to pinpoint the timing of the changes in survival over an extended period. Here, we compared the relative survival rates for colon, rectal and small intestinal cancers from Denmark (DK), Finland (FI), Norway (NO) and Sweden (SE). Design: Relative 1-, 5- and 5/1-year conditional survival data were obtained from the NORDCAN database for the years 1971-2020. Results: The 50-year survival patterns were country-specific. For colon and rectal cancers, the slopes of survival curves bended upwards for DK, were almost linear for NO and bended downwards for FI and SE; 5-year survival was the highest in DK. Survival in small intestinal cancer was initially below colon and rectal cancers but in FI and NO it caught up toward the end of the follow-up. Conclusions: Relative survival in intestinal cancers has developed well in the Nordic countries, and DK is an example of a country which in 20 years was able to achieve excellent survival rates in colon and rectal cancers. In the other countries, the increase in survival curves for colon and rectal cancer has slowed down, which may be a challenge posed by metastatic cancers.

  • Název v anglickém jazyce

    Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century

  • Popis výsledku anglicky

    Simple Summary Survival in colon and rectal cancers has internationally developed well, although reliable data span essentially only two decades. For small intestinal cancer, fewer data are available but survival appears to be improving. Overall, the exact causes of survival improvements are not known. During the 50-year period, 5-year survival in colon and rectal cancers improved linearly in Norway, while in Finland and Sweden the rate of improvement decreased with time, which is the opposite to Denmark where the rate increased. In small intestinal cancers, the rate of improvement was linear or increasing. The remarkable Danish achievement of improving relative survival rates more than the other counties coincided with cancer policy planning and instigating economically backed organizational and infrastructural improvements. The slowing survival rates in the other countries call for optimization of the available resources and a search for novel approaches. Background: Survival studies in intestinal cancers have generally shown favorable development, but few studies have been able to pinpoint the timing of the changes in survival over an extended period. Here, we compared the relative survival rates for colon, rectal and small intestinal cancers from Denmark (DK), Finland (FI), Norway (NO) and Sweden (SE). Design: Relative 1-, 5- and 5/1-year conditional survival data were obtained from the NORDCAN database for the years 1971-2020. Results: The 50-year survival patterns were country-specific. For colon and rectal cancers, the slopes of survival curves bended upwards for DK, were almost linear for NO and bended downwards for FI and SE; 5-year survival was the highest in DK. Survival in small intestinal cancer was initially below colon and rectal cancers but in FI and NO it caught up toward the end of the follow-up. Conclusions: Relative survival in intestinal cancers has developed well in the Nordic countries, and DK is an example of a country which in 20 years was able to achieve excellent survival rates in colon and rectal cancers. In the other countries, the increase in survival curves for colon and rectal cancer has slowed down, which may be a challenge posed by metastatic cancers.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30204 - Oncology

Návaznosti výsledku

  • Projekt

    <a href="/cs/project/LX22NPO5102" target="_blank" >LX22NPO5102: Národní ústav pro výzkum rakoviny</a><br>

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2023

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Cancers

  • ISSN

    2072-6694

  • e-ISSN

    2072-6694

  • Svazek periodika

    15

  • Číslo periodika v rámci svazku

    3

  • Stát vydavatele periodika

    CH - Švýcarská konfederace

  • Počet stran výsledku

    13

  • Strana od-do

    991

  • Kód UT WoS článku

    000933768300001

  • EID výsledku v databázi Scopus

    2-s2.0-85147809887